Evaluation of an education method on the severity of the Atopic Dermatitis disease and on the quality of life of children and their guardians
- Conditions
- Atopic dermatitis16.320.850
- Registration Number
- RBR-3m97hhq
- Lead Sponsor
- Complexo Hospital de Clínicas da Universidade Federal do Paraná
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruitment completed
- Sex
- Not specified
- Target Recruitment
- Not specified
Children under the age of 15 and their respective primary caregiver who attend the consultation at the Pediatric Dermatology service of the Hospital de Clínicas Complex; children who meet the Hanifin and Rajka criteria for the clinical diagnosis of atopic dermatitis; children who do not have other chronic diseases, with the exception of mild asthma and rhinitis; children accompanied by their primary caregivers; literate caregivers who answer the Quality of Life questionnaires; guardians who have a cell phone that supports the Whatsapp® application and have enabled the read confirmation option and who have an active phone line and mobile Internet or WiFi available; who agree to participate and sign the Informed Consent Form and Informed Consent Form, when applicable
They started using immunosuppressants during the evaluation period or up to 2 months before inclusion in the study; who do not return for revaluations in the specified period; withdraw the Free and Informed Consent form and the Free and Informed Consent Term
Study & Design
- Study Type
- Intervention
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Decrease in the severity of atopic dermatitis, through the receipt of text messages with information about the disease, based on the finding of a significantly statistical decrease in the severity scores of atopic dermatitis
- Secondary Outcome Measures
Name Time Method Improvement in the quality of life of participants with atopic dermatitis, through the receipt of text messages with information about the disease, based on the observation of a significantly statistical increase in the scores in the quality of life questionnaires in atopic dermatitis.